Facebook Pixel Code
Research Ethics Banner Image
Research Ethics Board

Fees

Effective November 2, 2015, the following Research Ethics Board (REB) review fees will be implemented. These fees cover costs of initial and on-going review of all new applications for industry-funded research studies.

Please note that research supported by public funds (i.e., CIHR) is not subject to these fees. All funds are in Canadian currency.

  • Initial REB Review: $3,000
  • Study Renewals: $500
  • Protocol Amendments: $500

Review fees

Initial REB Review Fee: $3,000

For review of new ethics applications funded by a for-profit entity (i.e., pharmaceutical/medical device company).

Study Renewal Review Fee: $500

For review of study renewal applications of ongoing research studies (annual or otherwise) funded by a for-profit entity (i.e., pharmaceutical/medical device company).

Protocol Amendment Review Fee: $500

For review of amendments involving revisions to the study protocol and/or patient safety changes to the consent documents. Amendments that do not include changes to the study protocol and/or patient safety information will not be subject to this fee. 

Invoicing and payment

All REB fees are charged regardless of the level of review required (full board vs. delegated) or the outcome of the review. All invoicing and payment is handled by the SickKids Research Awards and Financial Services (RAFS). Please contact RAFS for more information regarding invoicing, billing of REB fees.

Questions or concerns respecting this notice may be directed to the Manager of the Research Ethics Office (REO) at 416-813-7654 ext. 205718, or by email at david.kenney@sickkids.ca.